{
    "eid": "2-s2.0-85089108920",
    "title": "Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Antioxidants",
        "Biomarkers",
        "Inflammation",
        "Neuro-immune",
        "Oxidative stress",
        "Tryptophan"
    ],
    "authors": [
        "Michael Maes",
        "Sunee Sirivichayakul",
        "Andressa Keiko Matsumoto",
        "Ana Paula Michelin",
        "Laura de Oliveira Seme\u00e3o",
        "Jo\u00e3o Victor de Lima Pedr\u00e3o",
        "Estefania G. Moreira",
        "Decio S. Barbosa",
        "Andre F. Carvalho",
        "Marco Solmi",
        "Buranee Kanchanatawan"
    ],
    "citedby-count": 27,
    "ref-count": 84,
    "ref-list": [
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome",
        "Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "In schizophrenia, increased plasma IgM/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype",
        "Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation",
        "Oxidative & nitrosative stress in depression: why so much stress?",
        "Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone",
        "First-episode psychosis is associated with oxidative stress: effects of short-term antipsychotic treatment",
        "Pro\u2212/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia",
        "Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity",
        "Antipsychotic treatment reduces indices of oxidative stress in first-episode psychosis patients",
        "Oxidative and nitrosative stress biomarkers in chronic schizophrenia",
        "Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: a systematic review and meta-analysis",
        "Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis",
        "Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis",
        "Antioxidant defense in schizophrenia and bipolar disorder: a meta-analysis of MRS studies of anterior cingulate glutathione",
        "A meta-analysis of oxidative stress markers in schizophrenia",
        "Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations",
        "The brief psychiatric rating scale",
        "A rating scale for depression",
        "Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "Improved detection of advanced oxidation protein products in plasma",
        "Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle",
        "Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy",
        "Semiautomated measurement of nitrate in biological fluids",
        "Oxidative stress in blood of HIV infected patients",
        "Measurement of protein thiol groups and glutathione in plasma",
        "The analytical performance of a microplatemethod for total sulfhydryl measurement in biological samples",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "Structural equation modeling with the SmartPLS",
        "Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study",
        "Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis",
        "Chlorinative stress: an under appreciated mediator of neurodegeneration?",
        "Chlorinative stress in age-related diseases: a literature review",
        "Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases",
        "Advanced oxidation protein products induce apoptosis, and upregulate sclerostin and RANKL expression, in osteocytic MLO-Y4 cells via JNK/p38 MAPK activation",
        "Dietary protein oxidation: a silent threat to human health?",
        "Oxidative stress and neurodegeneration: where are we now?",
        "Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia",
        "Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: a follow-up study",
        "Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift",
        "Iron and oxidative stress in Parkinson\u2019s disease: an observational study of injury biomarkers",
        "Generalized anxiety disorder (GAD) and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses",
        "Increased root canal endotoxin levels are associated with chronic apical periodontitis, increased oxidative and nitrosative stress, major depression, severity of depression, and a lowered quality of life",
        "Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby",
        "Selective visualization of endogenous hypochlorous acid in zebrafish during lipopolysaccharide-induced acute liver injury using a polymer micelles-based ratiometric fluorescent probe",
        "Pattern recognition receptor function in neutrophils",
        "Antioxidants and their measurement",
        "Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches",
        "Redox modifications of protein-thiols: emerging roles in cell signaling",
        "Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia",
        "Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia",
        "Why should psychiatrists and neuroscientists worry about paraoxonase 1?",
        "Paraoxonase 1 and HDL maturation",
        "Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex",
        "Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids",
        "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis",
        "Paraoxonase-1 as a regulator of glucose and lipid homeostasis: Impact on the onset and progression of metabolic disorders",
        "Hyperhomocysteinemia as a risk factor for the neuronal system disorders",
        "Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex",
        "Executive functioning in schizophrenia",
        "Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia",
        "The reification of diagnosis in psychiatry",
        "Cross-validation of functional MRI and paranoid-depressive scale: results from multivariate analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Padua",
            "@id": "60000481",
            "affilname": "Universit\u00e0 degli Studi di Padova",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000481",
            "affiliation-country": "Italy"
        }
    ],
    "funding": [
        "EGM",
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}